skip to main content
Idioma:
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting Observations From the TIMI-38 Coronary Stent Registry
Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting Observations From the TIMI-38 Coronary Stent Registry
Material Type:
Artigo 		Adicionar ao Meu Espaço

Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting Observations From the TIMI-38 Coronary Stent Registry

Marc P. Bonaca Sabina A Murphy; Debra Miller; Jean-Paul R Herrman; Shmuel Gottlieb; Matyas Keltai; Alberto Menozzi; Jose C Nicolau; Petr Widimsky; Elliott M Antman; Stephen D Wiviott

Clinical Cardiology New York v. 37, n. 5, p. 293-299, 2014

New York 2014

Localização: FM - Fac. Medicina    (BCSEP 039 2014 )(Acessar)

2
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61) a randomised, placebo-controlled trial
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61) a randomised, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61) a randomised, placebo-controlled trial

Erin A. Bohula Benjamin M Scirica; Silvio E Inzucchi; Darren K Mcguire; Anthony C Keech; Steven R Smith; Estella Kanevsky; Sabina A Murphy; Lawrence A Leiter; Jose Carlos Nicolau

Lancet v. 392, n. 10161, p. 2269-2279, 2018

New York 2018

Acesso online. A biblioteca também possui exemplares impressos.

3
Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the trial to assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With prasugrel-thrombolysis in myocardial infarction 38 an application of the classification system from the universal definition of myocardial infarction
Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the trial to assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With prasugrel-thrombolysis in myocardial infarction 38 an application of the classification system from the universal definition of myocardial infarction
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the trial to assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With prasugrel-thrombolysis in myocardial infarction 38 an application of the classification system from the universal definition of myocardial infarction

David A. Morrow Stephen D Wiviott; Harvey D White; José Carlos Nicolau; Ezio Bramucci; Sabina A Murphy; Alberto Farias; Marc P Bonaca; Christian T Ruff; Benjamim M Scirica; Carolyn H McCabe; Elliott M Antman; Eugene Braunwald

Circulation. Journal of the american heart association Texas v. 119, n. 21, p. 2758-2764, 2009

Texas 2009

Localização: FM - Fac. Medicina    (FM BCBIB )(Acessar)

4
Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the trial to assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With prasugrel-thrombolysis in myocardial infarction 38 an application of the classification system from the universal definition of myocardial infarction
Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the trial to assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With prasugrel-thrombolysis in myocardial infarction 38 an application of the classification system from the universal definition of myocardial infarction
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the trial to assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With prasugrel-thrombolysis in myocardial infarction 38 an application of the classification system from the universal definition of myocardial infarction

David A. Morrow Stephen D Wiviott; Harvey D White; José Carlos Nicolau; Ezio Bramucci; Sabina A Murphy; Alberto Farias; Marc P Bonaca; Christian T Ruff; Benjamim M Scirica; Carolyn H McCabe; Elliott M Antman; Eugene Braunwald

Circulation. Journal of the american heart association Texas v. 119, n. 21, p. 2758-2764, 2009

Texas 2009

Localização: FM - Fac. Medicina    (FM BCBIB )(Acessar)

5
The Efficacy and Safety of Low-Dose Rivaroxaban With or Without a Proton Pump Inhibitor Insights From the ATLAS ACS 2-TIMI 51 Trial
The Efficacy and Safety of Low-Dose Rivaroxaban With or Without a Proton Pump Inhibitor Insights From the ATLAS ACS 2-TIMI 51 Trial
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

The Efficacy and Safety of Low-Dose Rivaroxaban With or Without a Proton Pump Inhibitor Insights From the ATLAS ACS 2-TIMI 51 Trial

Michelle L. O'Donoghue Jessica L Mega; Eugene Braunwald; Jose C Nicolau; Deepak L Bhatt; Sabina A Murphy; C. Michael Gibson; American Heart Associations of the Scientific Sessions and Resuscitation Science Symposium (2013 Dallas)

Circulation Dallas v. 128, n. 22, abst. 11382, 2013

Dallas 2013

Acesso online. A biblioteca também possui exemplares impressos.

6
Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States
Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States

Giulia Magnani Marc P Bonaca; Eugene Braunwald; Anthony J Dalby; Keith A. A Fox; Sabina A Murphy; José Carlos Nicolau; Ton Oude Ophuis; Benjamin M Scirica; Jindrich Spinar; Pierre Theroux; David A Morrow

Journal of the American Heart Association Oxford v. 4, n. art., e001505, 9 p. 2015

Oxford 2015

Acesso online. A biblioteca também possui exemplares impressos.

7
High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial
High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial

Alon Eisen Marc P Bonaca; Benjamin M Scirica; Harvey D White; Michal Tendera; Mikael Dellborg; Jose C Nicolau; Joao Morais; Keith A. A Fox; Erin A Bohula; Sabina A Murphy; Eugene Braunwald; David A Morrow

Clinical Chemistry Washington v. 63, n. 1, p. 307-315, 2017

Washington 2017

Acesso online. A biblioteca também possui exemplares impressos.

8
Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction Subanalysis From the DECLARE-TIMI 58 Trial
Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction Subanalysis From the DECLARE-TIMI 58 Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction Subanalysis From the DECLARE-TIMI 58 Trial

Remo H. M Furtado Marc P Bonaca; Itamar Raz; Thomas A Zelniker; Ofri Mosenzon; Avivit Cahn; Julia Kuder; Sabina A Murphy; Deepak L Bhatt; José Carlos Nicolau

Circulation v. 139, n. 22, p. 2516-2527, 2019

Philadelphia 2019

Acesso online. A biblioteca também possui exemplares impressos.

9
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure Observations From DECLARE-TIMI 58 Trial
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure Observations From DECLARE-TIMI 58 Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure Observations From DECLARE-TIMI 58 Trial

Remo H. M. Furtado Itamar Raz; Erica L Goodrich; Sabina A Murphy; Deepak L Bhatt; Lawrence A Leiter; Darren K Mcguire; John P. H Wilding; Philip Aylward; Anthony J Dalby; Jose Carlos Nicolau

Circulation v. 145, n. 21, p. 1581-1591, 2022

Philadelphia 2022

Acesso online. A biblioteca também possui exemplares impressos.

10
The Invasive Liriomyza huidobrensis (Diptera: Agromyzidae) understanding its pest status and management globally
The Invasive Liriomyza huidobrensis (Diptera: Agromyzidae) understanding its pest status and management globally
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Invasive Liriomyza huidobrensis (Diptera: Agromyzidae) understanding its pest status and management globally

Phyllis G Weintraub Sonja J Scheffer; Diedrich Visser; Graciela Valladares; Alberto Soares Correa; B. Merle Shepard; Aunu Rauf; Sean T Murphy; Norma Mujica; Charles MacVean; Jürgen Kroschel; Miriam Kishinevsky; Ravindra C Joshi; Nina S Johansen; Rebecca H Hallett; Hasan S Civelek; Bing Chen; Helga Blanco Metzler

Journal of Insect Science Tucson v. 17, n. 1, p. 1-27, 2017

Tucson 2017

Item não circula. Consulte sua biblioteca.(Acessar)

Personalize Seus Resultados

  1. Editar

Refine Search Results

Mostrar Somente

  1. Disponível na Biblioteca (64)
  2. Recursos Online (20)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (96)
  2. Livros  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1998  (9)
  2. 1998Até2007  (20)
  3. 2008Até2012  (25)
  4. 2013Até2018  (31)
  5. Após 2018  (12)
  6. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Murphy, D
  2. Murphy, S
  3. Murphy, E
  4. Sabino, E
  5. Braunwald, E

Neste Assunto:

  1. Transfusão De Sangue
  2. Fatores De Risco
  3. Infarto Do Miocárdio
  4. Vasopressinas
  5. Fisiologia

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.